Seeing further.

THAT’S OUR TARGET

We’re advancing our RNA-based treatments so patients with cancers and rare diseases can enjoy the moments that matter.

Learn More

Transforming Immunity. Restoring Hope.

We’re committed to redefining the treatment of certain cancers and rare diseases.

Learn More

Scientists. Believers. People.

At Idera, we’re working hard to translate our nucleic acid science into life-changing medicines.

Discover Idera

The Latest

Keep up with what’s happening at Idera Pharmaceuticals.

News

Idera Pharmaceuticals Announces Appointment of Dr. Maxine Gowen to Its Board of Directors

CAMBRIDGE, Mass. and EXTON, Pa., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc.… Read more 

Idera to Present at the 34th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass. and EXTON, Pa., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc.… Read more 

Idera Pharmaceuticals Announces Initiation of Phase 1/2 Clinical Trial of Intra-tumoral IMO-2125 in Combination With Ipilimumab in Patients With Metastatic Melanoma

CAMBRIDGE, Mass. and EXTON, Pa., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc.… Read more 

Learn More

Events

Sat, 06 Feb 2016 00:33:24 GMT

Idera Pharmaceuticals, Inc. Calendar Events

A Collection of Idera Pharmaceuticals, Inc. Calendar Events… Read more 

Learn More